NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

IMV Inc (TO: IMV)

 
IMV Technical Analysis
4
As on 8th Jun 2023 IMV STOCK Price closed @ 1.12 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.14 & Strong Sell for SHORT-TERM with Stoploss of 1.58 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

IMVSTOCK Price

Open 1.12 Change Price %
High 1.12 1 Day 0.00 0.00
Low 1.12 1 Week 0.00 0.00
Close 1.12 1 Month 0.12 12.00
Volume N/A 1 Year -0.56 -33.33
52 Week High 4.97 | 52 Week Low 0.30
 
TO Canada Most Active Stocks
YRI 7.89 0.13%
CNQ 42.50 0.05%
ENB 59.43 1.49%
BB 5.27 23.13%
ABX 22.22 1.41%
TWM 0.12 0.00%
FCU 0.74 -2.63%
PPL 52.36 0.89%
CVE 20.71 0.24%
TD 76.09 0.44%
 
TO Canada Top Gainers Stocks
CUB 0.21 950.00%
CUB 0.21 950.00%
BNG 0.02 100.00%
APS 0.42 75.00%
APS 0.42 75.00%
APS 0.42 75.00%
GGA 0.03 50.00%
MIN 0.20 42.86%
MIN 0.20 42.86%
MIN 0.20 42.86%
 
TO Canada Top Losers Stocks
MOZ 0.16 -80.25%
MOZ 0.16 -80.25%
LEV 0.34 -29.17%
LEV 0.34 -29.17%
LEV 0.34 -29.17%
GRC 0.06 -25.00%
GRC 0.06 -25.00%
GRC 0.06 -25.00%
GRC 0.06 -25.00%
GRC 0.06 -25.00%
 
 
IMV
Daily Charts
IMV
Intraday Charts
Whats New @
Bazaartrend
IMV
Free Analysis
 
IMV Important Levels Intraday
RESISTANCE1.12
RESISTANCE1.12
RESISTANCE1.12
RESISTANCE1.12
RESISTANCE1.12
RESISTANCE1.12
RESISTANCE1.12
RESISTANCE1.12
 
IMV Forecast December 2024
4th UP Forecast1.93
3rd UP Forecast1.67
2nd UP Forecast1.51
1st UP Forecast1.35
1st DOWN Forecast0.89
2nd DOWN Forecast0.73
3rd DOWN Forecast0.57
4th DOWN Forecast0.31
 
IMV Weekly Forecast
4th UP Forecast1.51
3rd UP Forecast1.38
2nd UP Forecast1.31
1st UP Forecast1.23
1st DOWN Forecast1.01
2nd DOWN Forecast0.93
3rd DOWN Forecast0.86
4th DOWN Forecast0.73
 
IMV Forecast2024
4th UP Forecast12.1
3rd UP Forecast8.58
2nd UP Forecast6.4
1st UP Forecast4.23
1st DOWN Forecast-1.99
2nd DOWN Forecast-4.16
3rd DOWN Forecast-6.34
4th DOWN Forecast-9.86
 
 
IMV Other Details
Segment EQ
Market Capital 156892368.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
IMV Address
IMV
 
IMV Latest News
 
Your Comments and Response on IMV Inc
 
IMV Business Profile
IMV Inc., a biopharmaceutical company, focuses on the development of cancer immunotherapies and vaccines against infectious diseases using its DPX delivery technology platform. The company's lead drug candidate includes maveropepimut-S (DPX-Survivac), a T cell therapy, which is in three Phase II clinical trials across 6 different cancer indications with and without Merck's Keytruda; and Phase II clinical trials for the treatment of ovarian cancer, and recurrent and refractory diffuse large B cell lymphoma. It is also developing DPX-COVID-19, a second-generation vaccine against severe acute respiratory syndrome coronavirus 2; and DPX-RSV, a vaccine candidate, which has completed Phase I clinical trials for the treatment of respiratory syncytial virus strain A, as well as DPX-SurMAGE for the treatment of bladder cancer and DPX-BRAF to treat melanoma patients. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada. Address: 130 Eileen Stubbs Avenue, Dartmouth, NS, Canada, B3B 2C4
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service